Key result
This review summarizes interesting studies in the field of diabetic neuropathy presented at the 82nd ADA Scientific Sessions and the 58th EASD Annual Meeting.
Why the study?
To describe interesting studies in the field of diabetic neuropathy presented at the 82nd ADA Scientific Sessions and the 58th EASD Annual Meeting.
Summarizes recent studies on diabetic neuropathy presented at the 2022 ADA and EASD meetings.
Should not change practice based on conference summaries of diabetic neuropathy; leaves open need for peer-reviewed validation.
Diabetic neuropathy is one of the commonest diabetic complications. It affects 30-50% of people with diabetes mellitus (DM) and may cause severe pain and foot ulcers. Distal symmetric polyneuropathy and diabetic autonomic neuropathy are the main manifestations of diabetic neuropathy. The American Diabetes Association's (ADA) 82nd Scientific Sessions took place in June 2022 in New Orleans, Louisiana, and the 58th European Association for the Study of Diabetes (EASD) Annual Meeting was held in September 2022 in Stockholm, Sweden. Herein, we describe interesting studies in the field of diabetic neuropathy presented in these two meetings.
No takes yet. Share an insight, caveat, or question.
Tentolouris et al. (2023) conducted a review in Diabetic neuropathy. This review summarizes interesting studies in the field of diabetic neuropathy presented at the 82nd ADA Scientific Sessions and the 58th EASD Annual Meeting.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: